Skip to Main Content

Paper Details

Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci.
Nat Genet
291
2015
-bound enhancer, Credible set variants, FOXA2, FOXA2 chromatin immunoprecipitation binding sites, FOXA2-bound enhancer, KCNQ1, MTNR1B, NEUROD1, T2D, human, human islet, human islet and liver cells, implicated, islet, islet-, islet- and liver-derived cells, islet-derived cells, noncoding sequence, risk allele, rs10830963, type 2 diabetes, type 2 diabetes (T2D) loci, type 2 diabetes susceptibility loci
Author NameAffiliation
Kyle J GaultonUniversity of Oxford
Kyle J GaultonStanford University
Teresa FerreiraUniversity of Oxford
Yeji LeeUniversity of Michigan ann arbor
Anne RaimondoUniversity of Oxford
Reedik MägiUniversity of Tartu
Michael E ReschenUniversity of Oxford
Anubha MahajanUniversity of Oxford
Adam E LockeUniversity of Michigan ann arbor
Nigel W RaynerUniversity of Oxford
Nigel W RaynerWellcome Trust Sanger Institute
Nigel W RaynerUniversity of Oxford
Neil R RobertsonUniversity of Oxford
Neil R RobertsonUniversity of Oxford
Robert A ScottMedical Research Council (MRC) Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science
Inga ProkopenkoImperial College London
Laura J ScottUniversity of Michigan ann arbor
Todd GreenBroad Institute of Harvard and MIT
Thomas SparsøNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen
Dorothée ThuillierLille Institute of Biology, European Genomics Institute of Diabetes
Loic YengoLille Institute of Biology, European Genomics Institute of Diabetes
Harald GrallertResearch Unit of Molecular Epidemiology, Helmholtz Zentrum Munchen-German Research Center for Environmental Health
Harald GrallertGerman Center for Diabetes Research
Harald GrallertInstitute of Epidemiology II, Helmholtz Zentrum Munchen-German Research Center for Environmental Health
Simone WahlResearch Unit of Molecular Epidemiology, Helmholtz Zentrum Munchen-German Research Center for Environmental Health
Simone WahlGerman Center for Diabetes Research
Simone WahlInstitute of Epidemiology II, Helmholtz Zentrum Munchen-German Research Center for Environmental Health
Mattias FrånbergAtherosclerosis Research Unit, Karolinska Institutet
Mattias FrånbergStockholm University
Mattias Frånberg
Rona J StrawbridgeAtherosclerosis Research Unit, Karolinska Institutet
Hans A KestlerLeibniz Institute for Age Research, Fritz Lipmann Institute
Hans A KestlerUlm University
Himanshu ChhedaFinnish Institute for Molecular Medicine (FIMM)
Lewin EiseleInstitute for Medical Informatics, University Hospital of Essen
Stefan GustafssonUppsala University
Stefan GustafssonUppsala University
Valgerdur SteinthorsdottirInc.
Gudmar ThorleifssonInc.
Gudmar ThorleifssonInc.
Lu QiHarvard School of Public Health
Lu QiSchool of Public Health and Tropical Medicine, Tulane University
Lu QiBrigham and Women's Hospital and Harvard Medical School
Lu QiHarvard School of Public Health
Lennart C KarssenErasmus University Medical Center
Elisabeth M van LeeuwenErasmus University Medical Center
Sara M WillemsMedical Research Council (MRC) Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science
Sara M WillemsErasmus University Medical Center
Man LiJohns Hopkins Bloomberg School of Public Health
Man LiJohns Hopkins Bloomberg School of Public Health
  • 1 - 50

Datasets